NEW YORK, June 18, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 80 companies including many key and niche players such as -
Abbott Laboratories
Beckman Coulter, Inc.
bioMérieux SA
Bio-Rad Laboratories Inc.
Ortho-Clinical Diagnostics Inc.
Read the full report: http://www.reportlinker.com/p0305127-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Enzyme Immunoassay I-4
Fluorescence Immunoassay I-4
Chemiluminescence Immunoassay I-4
Radioimmunoassay I-4
Nephelometric Immunoassay I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Immunoassays - A Preface II-1
Current and Future Analysis II-3
Factors Sustaining Market Growth II-3
Factors Restraining Growth II-3
Developing Markets to Turbo Charge Growth in the Market II-4
Innovation - Name of the Game II-4
Automated Multiplexing Platforms Present Growth Opportunities II-5
Improving Healthcare Expenditure to Foster Growth II-6
Table 1: Per-Capita Healthcare Expenditure in Select Regions
(2013) (includes corresponding Graph/Chart) II-6
Table 2: Top 20 Countries with the Highest Healthcare
Spending as a Percentage of GDP: 2012 (includes corresponding
Graph/Chart) II-7
Aging Global Population Buoys Market Growth II-7
Table 3: Global Population Statistics for the 65+ Age Group
(Male & Female) for Major Countries/Regions: 2013E (includes
corresponding Graph/Chart) II-8
Novel Biomarkers & Advanced Technologies to Boost Market II-9
Expanding Immunoassay Applications Boost Demand for
Immunoassay Systems II-9
Table 4: Global Laboratory Based Immunoassay Market (2013):
Percentage Share Breakdown of Value Sales by Clinical Area
(includes corresponding Graph/Chart) II-10
2. COMPETITIVE LANDSCAPE II-11
List of Select Commercially Available Immunoassay Instruments II-12
Table 5: Leading Players in the Global Immunoassays Market
for Infectious Diseases (2013) - Percentage Share Breakdown
of Revenues for Siemens, Abbott, Roche, bioMerieux, sorin,
and Others (includes corresponding Graph/Chart) II-12
Table 6: Leading Players in the Global Immunoassays Market
for Oncology / Endocrinology (2013) - Percentage Share
Breakdown of Revenues for Siemens, Abbott, Roche, and Others
(includes corresponding Graph/Chart) II-12
New Product Launches Swarm the Market II-13
A Look into New Product Introductions/ Approvals in 2013 II-13
3. MARKET TRENDS AND ISSUES II-14
Automated Immunoassay Systems - In Line with Automation Trend II-14
List of Select Automated Immunoassay Instrument Platforms II-15
Shortened Hospital Stays Enhance Significance of Medical Labs II-19
Increasing Use of Immunoassays in Food Sciences and Quality
Control II-19
Growing Use in Environmental Testing II-20
Advancement in Genetic Research Drives the Growth II-20
POC and DIA Systems Grow in Demand II-20
Portable Immunoassay Systems Energizes the Market II-21
Challenges Stifle Bio-Marker Research II-21
Immunochemistry Analyzers: Gaining Traction II-22
4. AN INSIGHT INTO IMMUNOASSAY TECHNOLOGIES II-23
Comparison of Various Immunoassay Technologies II-24
ELISA - A Renowned and Proven Assay Format II-24
ELISA Products of Select Manufacturers II-25
Technological Advances to buoy ELISA's Prospects II-26
Automation of ELISA - Enabling its Sustenance II-27
Growing Popularity of Multiplexing Deters ELISA Market II-27
Commoditization: A Key Issue Facing ELISA Product Manufacturers II-27
Radioimmunoassay Systems Lose Sheen II-28
Chemiluminescence Immunoassays Gain Ground II-29
5. IMMUNOASSAY APPLICATIONS - A REVIEW II-30
Infectious Disease Diagnosis: The Largest Application Area II-30
Increasing Incidence of Infectious Diseases - An Opportunity
Indicator II-30
Table 7: Reported Cases of Major Infections by Select
Geographic Region: 2011 II-30
Endocrine Testing Procedures II-31
Growing Diabetes Prevalence Boost Prospects for Immunoassay-
based HbA1c Tests II-31
Table 8: Worldwide Prevalence of Diabetes Mellitus by Region
(2013 & 2035) (includes corresponding Graph/Chart) II-33
Table 9: Incidence of Diabetes in Select Countries (2013 &
2035) (includes corresponding Graph/Chart) II-33
Table 10: World's Health Expenditure on Diabetes by Region
(2013E): Spending (in US$ Billion) by People Diagnosed with
Diabetes in the Age Group 20-79 Years to Treat Diabetes and
Manage Associated Complications (includes corresponding
Graph/Chart) II-34
Table 11: Global Expenditure on Diabetes Treatment (2012):
Spending (in US$ Billion) by Income Strata (includes
corresponding Graph/Chart) II-34
Blood Processing Market II-35
Cancer Testing Markets II-35
Drugs of Abuse Testing Market II-35
Therapeutic Drug Monitoring II-36
Immune Disease II-36
Blood Grouping and Typing II-36
Rapid Tests Encroach Allergy Testing Market II-37
6. CONCEPTUAL OVERVIEW II-38
Immunoassays - Definition and Description.... II-38
Down the Timeline II-38
Immunoassay Analyzers II-38
Immunoassay Reagents II-39
Radioimmunoassay II-39
Non-Isotopic Immunoassays II-39
Customized Immunoassays II-40
Components of Immunoassays II-40
Signal Response II-40
Labeled Tracer II-40
Binder II-41
Buffer Matrix II-41
Incubation Conditions II-41
Separation Process II-41
Standard Specimens II-41
Control Specimens II-41
Unknown Specimens II-41
Types of Immunoassay Analyzers II-42
Enzyme Immunoassays II-42
Automation Enabled II-43
Customization of Assays II-43
ELISA - A Flexible Enzyme Immunoassay Test..... II-43
Fluorescence Immunoassay - Operating Principle II-44
Light Sources II-44
Sample Cell II-44
Filters II-44
Detector II-45
Time-Resolved Fluoroimmunoassay II-45
Chemiluminescence Immunoassay II-45
Radioimmunoassay Analyzers, Gamma Counters II-46
Fundamentals of Operation II-46
Problems Involved II-47
Types of Immunoassay Techniques II-48
Fluorescence Polarization Immunoassay II-48
Radiative Energy Attenuation (REA) II-49
Substrate-Labeled Fluorescence II-49
Enzyme Immunoassay with Fluorescence Detection II-49
Solid-Phase Microsphere Immunoassay II-50
Microparticle Enzyme Immunoassay (MEIA) II-50
Enzyme-Linked Fluorescence Immunoassay II-50
ELISA With Photometric Detection II-50
Dry-Phase Techniques II-51
Problems and Limitations II-51
Purchase Considerations for Automated Analyzers II-51
7. MEDICAL DIAGNOSTICS MARKET - A REVIEW II-53
Clinical Diagnostics Industry - Market Overview and Trends II-53
Global In-Vitro Diagnostics (IVD) Market: A Prelude II-53
Impact of the Recession in Retrospect and the Road Ahead II-54
Factors Influencing IVD Industry: On a Scale of 1-5 II-56
Key Statistical Findings: II-56
Table 12: Global In-Vitro Diagnostics Market by Segment
(2013): Percentage Breakdown of Value Sales for Hematology,
Hemostasis, Immunochemistry, Microbiology, Molecular
Diagnostics, Point-of-Care Diagnostics, Self-Monitoring Blood
Glucose, and Tissue Diagnostics (includes corresponding
Graph/Chart) II-56
Table 13: Global In-Vitro Diagnostics Market by Sector
(2013): Percentage Breakdown of Revenues for Decentralized &
Patient Self-Testing and Hospital & Commercial Laboratories
(includes corresponding Graph/Chart) II-57
Table 14: World In-Vitro Diagnostic Products Market by Site
of Care (2013) - Percentage Breakdown by Value Sales for
Hospital Labs, Commercial Labs, Self-Testing and POC
(includes corresponding Graph/Chart) II-57
Table 15: Global In Vitro Diagnostics (IVD) Market by
Geographic Region (2013): Percentage Share Breakdown of
Revenues for the United States, Europe, and Rest of World
(includes corresponding Graph/Chart) II-57
Molecular Diagnostics - A Replacement and Enabling Technology II-58
8. PRODUCT LAUNCHES/APPROVALS II-59
Siemens Introduces New Chemistry & Immunoassay Systems II-59
Meso Scale Discovery Launches S-PLEX™ Assays II-59
Modern Water Monitoring Introduces New Immunoassay Strip Test
and Readers II-59
Enzo Life Sciences Launches Amp'd™ ELISA Signal Amplification Kit II-59
EMD Millipore Rolls Out New Immunoassay Kits II-59
PerkinElmer Launches Novel Research Tools II-59
Roche Releases Elecsys Syphilis Immunoassay II-60
ALPCO Releases STELLUX™ Chemiluminescence Human Total
Proinsulin ELISA II-60
InDevR Introduces miPLEX II-60
Siemens Healthcare Diagnostics Introduces New Alergans and Panels II-60
Randox Introduces New Immunoassay and Analyzer-specific BNP
Liquid Controls II-60
Randox Obtains FDA Approval for Acusera Immunoassay Specialty
1 Control II-60
Meso Scale Rolls Out V-PLEX Biomarker Immunoassays II-61
Abcam Introduces SimpleStep™ ELISA Kits II-61
Quidel Gets FDA Approval for Sofia(R) hCG Fluorescent Immunoassay II-61
Thermo Fisher Scientific Launches New Ready- to-Use Tacroliums
Immunoassay II-61
Meso Scale Discovery Introduces New Quickplex™ SQ 120
Multiplex Immunoassay Instrument II-61
AJ Roboscreen Gets Approval for Two ELISA-based Tests II-61
bioMérieux Launches VIDAS® 3 Automated Immunoassay System II-61
Bio-Rad Introduces New Bio-Plex Pro™ RBM Kidney Toxicity Panels II-62
INOVA Diagnostics Rolls Out BIO-FLASH II-62
Sysmex Introduces HISCL®-5000 II-62
Volition Introduces NuQ Epigenetic Immunoassays II-62
Quidel Obtains CE Mark for Sofia® RSV Fluorescent Immunoassay II-62
Zeus Scientific Gets FDA Approval for ZEUS ELISA™ Borrelia
VlsE1/pepC10 IgG/IgM Test System II-62
Salimetrics Launches Salivary IL-1 Beta Immunoassay Kit II-63
Beckman Coulter Obtains FDA 510(k) Clearance for AU5800
Chemistry Systems II-63
9. RECENT INDUSTRY ACTIVITY II-64
Eurofins Acquired ViraCor-IBT Laboratories II-64
YSL Bio Signs Enters into Agreement with GeneX II-64
Techne to Acquire CyVek II-64
Gyros Enters into Distribution Agreement with Tekon Biotech II-64
Singulex Partners with Tecan II-64
OriGene Technologies Takes Over BioCheck II-64
Techne Partners with Fisher Scientific II-65
Invetech Enters into 10-Year Agreement with Bio-Rad II-65
Diaxonhit Enters into Partnership with Tosoh Group II-65
Cisbio Bioassays and Orion Diagnostica Enter into Agreement II-65
Thermo Fisher Scientific and Siemens Renew Existing Agreement II-65
EMD Millipore Enters into Partnership with Gyros II-65
BioVendor Selects SCIENION's Integrated Product Portfolio for
Immunoassays Development II-66
bioMérieux and Quanterix Enter into Strategic Alliance II-66
Trivitron Healthcare and Diasorin Group Form New Joint Venture
Company II-66
Affymetrix Acquires eBioscience Holding Company II-66
Affinity Life Sciences Enters into Partnership with Prediction
Sciences II-66
Vital Diagnostics Inks Exclusive Agreement with Cardinal Health II-66
Gamma Therapeutics Enters into Manufacturing Contract with
ZEUS Scientific II-67
Dynex Technologies Enters into Supply Agreement with Zeus
Scientific II-67
10. FOCUS ON SELECT MARKET PARTICIPANTS II-68
Abbott Laboratories (US) II-68
Beckman Coulter, Inc. (US) II-68
bioMérieux SA (France) II-69
Bio-Rad Laboratories Inc. (US) II-69
Ortho-Clinical Diagnostics Inc (US) II-70
Roche Diagnostics (Switzerland) II-71
Siemens Healthcare Diagnostics (US) II-71
Sysmex Corporation (Japan) II-72
Quidel Corporation (US) II-72
DiaSorin S.p.A (Italy) II-73
Fujirebio Inc. (Japan) II-73
Tosoh Bioscience, Inc. (US) II-73
11. GLOBAL MARKET PERSPECTIVE II-74
Table 16: World Recent Past, Current & Future Analysis for
Immunoassay Systems by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) II-74
Table 17: World Historic Review for Immunoassay Systems by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific,
Latin America and Rest of World Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2006
through 2012 (includes corresponding Graph/Chart) II-75
Table 18: World 15-Year Perspective for Immunoassay Systems by
Geographic Region - Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-76
Immunoassay Systems Market by Product Segment II-77
Table 19: World Recent Past, Current & Future Analysis for
Enzyme Immunoassay Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-77
Table 20: World Historic Review for Enzyme Immunoassay Systems
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-78
Table 21: World 15-Year Perspective for Enzyme Immunoassay
Systems by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) II-79
Table 22: World Recent Past, Current & Future Analysis for
Fluorescence Immunoassay Systems by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of
World Markets Independently Analyzed With Annual Sales Figures
in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-80
Table 23: World Historic Review for Fluorescence Immunoassay
Systems by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-81
Table 24: World 15-Year Perspective for Fluorescence
Immunoassay Systems by Geographic Region - Percentage
Breakdown of Value Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-82
Table 25: World Recent Past, Current & Future Analysis for
Chemiluminescence Immunoassay Systems by Geographic Region -
US, Canada, Japan, Europe, Asia-Pacific, Latin America and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-83
Table 26: World Historic Review for Chemiluminescence
Immunoassay Systems by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-84
Table 27: World 15-Year Perspective for Chemiluminescence
Immunoassay Systems by Geographic Region - Percentage
Breakdown of Value Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-85
Table 28: World Recent Past, Current & Future Analysis for
Radio Immunoassay Systems by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Latin America and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-86
Table 29: World Historic Review for Radio Immunoassay Systems
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-87
Table 30: World 15-Year Perspective for Radio Immunoassay
Systems by Geographic Region - Percentage Breakdown of Value
Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin
America and Rest of World Markets for Years 2006, 2014 & 2020
(includes corresponding Graph/Chart) II-88
Table 31: World Recent Past, Current & Future Analysis for
Nephelometric Immunoassay Systems by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-89
Table 32: World Historic Review for Nephelometric Immunoassay
Systems by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-90
Table 33: World 15-Year Perspective for Nephelometric
Immunoassay Systems by Geographic Region - Percentage
Breakdown of Value Sales for US, Canada, Japan, Europe,
Asia-Pacific, Latin America and Rest of World Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-91
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Ageing Demographics: Major Driving Factor III-1
Table 34: North American Elderly Population by Age Group:
1975-2050 (includes corresponding Graph/Chart) III-2
Table 35: US Population Breakdown by Age Group: 2012
(includes corresponding Graph/Chart) III-2
Increasing Burden of Chronic Diseases Drives Focus onto
Immunoassays III-3
US In-Vitro Diagnostics Market - A Special Review III-3
Evolving Trends to Benefit IVD Market III-3
An Overview of ELISA Usage III-4
Product Launches/Approvals III-4
Strategic Corporate Developments III-7
Focus on Select Players III-9
B.Market Analytics III-14
Table 36: US Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-14
Table 37: US Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-15
Table 38: US 15-Year Perspective for Immunoassay Systems by
Product Segment - Percentage Breakdown of Value Sales for
Enzyme Immunoassay Systems, Fluorescence Immunoassay
Systems, Chemiluminescence Immunoassay Systems, Radio
Immunoassay Systems, and Nephelometric Immunoassay Systems
Markets for 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-16
2. CANADA III-17
Market Analysis III-17
Table 39: Canadian Recent Past, Current & Future Analysis
for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-18
Table 40: Canadian Historic Review for Immunoassay Systems
by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-19
Table 41: Canadian 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-20
3. JAPAN III-21
A.Market Analysis III-21
Outlook III-21
Demographics Drive Market Growth III-21
Table 42: Percentage Breakdown of Japanese Population by
Age Group (2012) (includes corresponding Graph/Chart) III-21
Table 43: Japanese 65+ Years Population: 1950-2010
(includes corresponding Graph/Chart) III-22
Product Launch III-22
Focus on Key Players III-22
B.Market Analytics III-24
Table 44: Japanese Recent Past, Current & Future Analysis
for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-24
Table 45: Japanese Historic Review for Immunoassay Systems
by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-25
Table 46: Japanese 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-26
4. EUROPE III-27
A.Market Analysis III-27
Current & Future Analysis III-27
Automation Supports Growth in Western European IVD Market III-27
Immunochemistry Analyzer Market III-27
Rationing Healthcare System Impacts Growth III-28
Trends in Immunodiagnostic Market..... III-30
Increasing Testing Needs of the Elderly: Business Case for
Immunoassays III-30
Table 47: Population Breakup by Age Group for Select
European Countries: 2012 (As a % of Total Population)
(includes corresponding Graph/Chart) III-31
Product Launch III-32
B.Market Analytics III-32
Table 48: European Recent Past, Current & Future Analysis
for Immunoassay Systems by Geographic Region - France,
Germany, Italy, the UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousand for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-32
Table 49: European Historic Review for Immunoassay Systems
by Geographic Region - France, Germany, Italy, the UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-33
Table 50: European Recent Past, Current & Future Analysis
for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-34
Table 51: European Historic Review for Immunoassay Systems
by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-35
Table 52: European 15-Year Perspective for Immunoassay
Systems by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, the UK, Spain, Russia and
Rest of Europe Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-36
Table 53: European 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-37
4a. FRANCE III-38
A.Market Analysis III-38
Current & Future Analysis III-38
Product Launch III-38
Strategic Corporate Development III-38
bioMérieux - A Key Player III-38
B.Market Analytics III-40
Table 54: French Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-40
Table 55: French Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-41
Table 56: French 15-Year Perspective for Immunoassay Systems
by Product Segment - Percentage Breakdown of Value Sales for
Enzyme Immunoassay Systems, Fluorescence Immunoassay
Systems, Chemiluminescence Immunoassay Systems, Radio
Immunoassay Systems, and Nephelometric Immunoassay Systems
Markets for 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-42
4b. GERMANY III-43
A.Market Analysis III-43
Current & Future Analysis III-43
Product Launches III-43
B.Market Analytics III-44
Table 57: German Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-44
Table 58: German Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-45
Table 59: German 15-Year Perspective for Immunoassay Systems
by Product Segment - Percentage Breakdown of Value Sales for
Enzyme Immunoassay Systems, Fluorescence Immunoassay
Systems, Chemiluminescence Immunoassay Systems, Radio
Immunoassay Systems, and Nephelometric Immunoassay Systems
Markets for 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-46
4c. ITALY III-47
A.Market Analysis III-47
DiaSorin S.p.A - A Key Player III-47
B.Market Analytics III-48
Table 60: Italian Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-48
Table 61: Italian Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-49
Table 62: Italian 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-50
4d. THE UNITED KINGDOM III-51
A.Market Analysis III-51
Current & Future Analysis III-51
Product Launches III-51
B.Market Analytics III-52
Table 63: UK Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-52
Table 64: UK Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-53
Table 65: UK 15-Year Perspective for Immunoassay Systems by
Product Segment - Percentage Breakdown of Value Sales for
Enzyme Immunoassay Systems, Fluorescence Immunoassay
Systems, Chemiluminescence Immunoassay Systems, Radio
Immunoassay Systems, and Nephelometric Immunoassay Systems
Markets for 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-54
4e. SPAIN III-55
Market Analysis III-55
Table 66: Spain Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-55
Table 67: Spain Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-56
Table 68: Spain 15-Year Perspective for Immunoassay Systems
by Product Segment - Percentage Breakdown of Value Sales for
Enzyme Immunoassay Systems, Fluorescence Immunoassay
Systems, Chemiluminescence Immunoassay Systems, Radio
Immunoassay Systems, and Nephelometric Immunoassay Systems
Markets for 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-57
4f. RUSSIA III-58
Market Analysis III-58
Table 69: Russian Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-58
Table 70: Russian Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-59
Table 71: Russian 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-60
4g. REST OF EUROPE III-61
A.Market Analysis III-61
Current and Future Analysis III-61
Product Launches III-61
Strategic Corporate Developments III-61
Roche Diagnostics - A Key Player III-62
B.Market Analytics III-63
Table 72: Rest of Europe Recent Past, Current & Future
Analysis for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-63
Table 73: Rest of Europe Historic Review for Immunoassay
Systems by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-64
Table 74: Rest of Europe 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-65
5. ASIA-PACIFIC III-66
A.Market Analysis III-66
Current and Future Analysis III-66
Growing In-Vitro Diagnostics (IVD) Market Fuels Demand for
Immunoassay Instruments III-66
India & China Offer Significant Growth Opportunities III-66
Table 75: China and India Leads Global Population (July
2013): Table Depicting China and India's Huge Population
Vis-a-vis Other Countries' Population (in Million) by Age
Group (includes corresponding Graph/Chart) III-67
Table 76: Age-wise Breakup of China and India's Population
Vis-à-vis Other Populous Countries Globally: As of July
2013 (includes corresponding Graph/Chart) III-68
Healthcare Spending in Asia-Pacific: On the Rise III-68
Product Registration: A Major Roadblock III-69
Distribution: A Major Challenge III-69
B.Market Analytics III-70
Table 77: Asia-Pacific Recent Past, Current & Future
Analysis for Immunoassay Systems by Geographic Region -
China, India and Rest of Asia-Pacific Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-70
Table 78: Asia-Pacific Historic Review for Immunoassay
Systems by Geographic Region - China, India and Rest of
Asia-Pacific Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-71
Table 79: Asia-Pacific Recent Past, Current & Future
Analysis for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-72
Table 80: Asia-Pacific Historic Review for Immunoassay
Systems by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-73
Table 81: Asia-Pacific 15-Year Perspective for Immunoassay
Systems by Geographic Region - Percentage Breakdown of Value
Sales for China, India and Rest of Asia-Pacific Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-74
Table 82: Asia-Pacific 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-75
5a. CHINA III-76
A.Market Analysis III-76
Current and Future Analysis III-76
In-Vitro Diagnostics Market on the Growth Curve III-76
Table 83: Leading Vendors in the Chinese IVD Market
(2013): Percentage Market Share Breakdown for Abbott,
Beckman/Danaher, bioMerieux, DAAN, Hitachi, J&J, Mindray,
Roche, Siemens, Sysmex and Others (includes corresponding
Graph/Chart) III-77
Diagnostics Products Market in China: A Review III-77
Competitive Analysis III-77
B.Market Analytics III-79
Table 84: Chinese Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-79
Table 85: Chinese Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-80
Table 86: Chinese 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-81
5b. INDIA III-82
A.Market Analysis III-82
Current and Future Analysis III-82
IVD Market in India: An Overview III-82
Immunoassays Market - An Overview III-82
Emerging Trends III-83
Competitive Scenario III-84
Leading Vendors of Immunochemistry Instruments and Reagents
in India III-84
Leading ELISA Kits Vendors in India III-84
Leading Vendors of Rapid Tests in India III-84
B.Market Analytics III-85
Table 87: Indian Recent Past, Current & Future Analysis for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-85
Table 88: Indian Historic Review for Immunoassay Systems by
Product Segment - Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-86
Table 89: Indian 15-Year Perspective for Immunoassay Systems
by Product Segment - Percentage Breakdown of Value Sales for
Enzyme Immunoassay Systems, Fluorescence Immunoassay
Systems, Chemiluminescence Immunoassay Systems, Radio
Immunoassay Systems, and Nephelometric Immunoassay Systems
Markets for 2006, 2014 & 2020 (includes corresponding
Graph/Chart) III-87
5c. REST OF ASIA-PACIFIC III-88
A.Market Analysis III-88
Current and Future Analysis III-88
Indonesia III-88
Malaysia III-88
Strategic Corporate Developments III-88
B.Market Analytics III-90
Table 90: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-90
Table 91: Rest of Asia-Pacific Historic Review for
Immunoassay Systems by Product Segment - Enzyme Immunoassay
Systems, Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-91
Table 92: Rest of Asia-Pacific 15-Year Perspective for
Immunoassay Systems by Product Segment - Percentage
Breakdown of Value Sales for Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets for 2006, 2014 &
2020 (includes corresponding Graph/Chart) III-92
6. LATIN AMERICA III-93
Market Analysis III-93
Table 93: Latin American Recent Past, Current & Future
Analysis for Immunoassay Systems by Geographic Region -
Brazil and Rest of Latin American Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2013 through 2020 (includes corresponding Graph/Chart) III-93
Table 94: Latin American Historic Review for Immunoassay
Systems by Geographic Region - Brazil and Rest of Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2012
(includes corresponding Graph/Chart) III-94
Table 95: Latin American Recent Past, Current & Future
Analysis for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-95
Table 96: Latin American Historic Review for Immunoassay
Systems by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-96
Table 97: Latin American 15-Year Perspective for Immunoassay
Systems by Geographic Region - Percentage Breakdown of Value
Sales for Brazil and Rest of Latin American Markets for
Years 2006, 2014 & 2020 (includes corresponding Graph/Chart) III-97
Table 98: Latin American 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-98
6a. BRAZIL III-99
Market Analysis III-99
Table 99: Brazilian Recent Past, Current & Future Analysis
for Immunoassay Systems by Product Segment - Enzyme
Immunoassay Systems, Fluorescence Immunoassay Systems,
Chemiluminescence Immunoassay Systems, Radio Immunoassay
Systems, and Nephelometric Immunoassay Systems Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2013 through 2020 (includes corresponding
Graph/Chart) III-99
Table 100: Brazilian Historic Review for Immunoassay Systems
by Product Segment - Enzyme Immunoassay Systems,
Fluorescence Immunoassay Systems, Chemiluminescence
Immunoassay Systems, Radio Immunoassay Systems, and
Nephelometric Immunoassay Systems Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2012 (includes corresponding Graph/Chart) III-100
Table 101: Brazilian 15-Year Perspective for Immunoassay
Systems by Product Segment - Percentage Breakdown of Value
Sales for Enzyme Immunoassay Systems, Fluorescence
Immunoassay Systems, Chemiluminescence Immunoassay Systems,
Radio Immunoassay Systems, and Nephelometric Immunoassay
Systems Markets for 2006, 2014 & 2020 (includes
corresponding Graph/Chart) III-101
6b. REST OF LATIN AMERICA III-102
Market Analysis III-102
Table 102
Read the full report: http://www.reportlinker.com/p0305127-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article